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Objective: We evaluated risk factors for mortality and stroke after mechan-
ical mitral valve replacement between May 1977 and December 2001.
Methods: Early and late mortality and stroke were assessed. Potential
predictors of mortality and stroke were entered into a Cox proportional
hazards model. Actuarial survival and freedom from stroke were deter-
mined by a log-rank test.
Results: Mitral valve replacement was performed in 812 patients. Con-
comitant procedures included left atrial appendage closure in 493 (61%)
patients, tricuspid annuloplasty-replacement in 348 (43%) patients, maze
procedure in 185 (23%) patients, plication of the left atrium in 148 (18%)
patients, and other procedures in 151 (19%) patients. Five-year actuarial
survival was 91.1%  2.3%. Freedom from stroke at 8 years was
significantly better in patients with sinus rhythm versus atrial fibrillation (P .001).
Ninety-nine percent of patients with mitral valve replacement combined with a maze
procedure were free from stroke, whereas only 89% of patients with mitral valve
replacement alone were free from stroke at 8 years after surgical intervention.
Seventy-two patients had late stroke; sixty-five patients (90%) were in atrial fibril-
lation, and 47 (65%) patients had the left atrial appendage closed. Multivariate
analysis showed that late atrial fibrillation (odds ratio, 3.39; 95% confidence
interval, 1.72-6.67; P  .0001) and omission of the maze procedure (odds ratio,
3.40; 95% confidence interval, 1.14-10.14; P  .003) were the significant risk
factors for late stroke.
Conclusions: Persistent atrial fibrillation was the most significant risk factor for late
stroke after mechanical mitral valve replacement. Restoration of sinus rhythm with a
maze procedure nearly eliminated the risk of late stroke, whereas neither closure of the
left atrial appendage nor therapeutic anticoagulation prevented this complication.
Despite improvements in valve design, stroke remains a seriouscomplication after heart valve replacement. It is generally agreedthat lifelong anticoagulant therapy is indicated in all patients withmechanical valves. Recent studies indicate that major systemicembolism still occurs at a rate of 2% to 3% per year aftermechanical mitral valve replacement (MVR), despite anticoagu-
lation.1-3 We and others recently demonstrated that maintaining sinus rhythm by
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using the Cox maze procedure reduced the incidence of late
stroke.4-6 However, the risk for late stroke after mechanical
valve replacement remains to be determined.
The purpose of the study was to elucidate the risks for
early and late mortality and stroke after mechanical MVR in
a single center over a 24-year period.
Patients and Methods
Between May 1977 and December 2001, we performed 812 MVRs
with mechanical prostheses. We retrospectively reviewed the data
from operative notes, anesthesia records, clinical case histories,
and laboratory investigations, including electrocardiograms, echo-
cardiograms, and cardiac catheterization reports. This retrospec-
tive study was approved by the Institutional Review Board of
National Cardiovascular Center. Follow-up data were collected
from the National Cardiovascular Center records of outpatient
visits and correspondence with referring physicians. Each patient
was followed by local physicians or by cardiologists or surgeons in
our hospital at least every 2 months. A total of 33 clinical,
hemodynamic, electrocardiographic, and echocardiographic vari-
ables were entered into a computerized database and analyzed.
Follow-up data beyond 6 months after the operation were available
for all patients.
Definitions
Stroke was defined as cerebral thromboembolism diagnosed by a
neurologist and confirmed by means of a computed tomographic
scan. Transient ischemic attacks were not counted as strokes in this
study. Valve thrombosis was defined as impairment of the valve
function by the deposition of thrombus demonstrated at operation
or autopsy. Bleeding includes intracranial bleeding, spinal bleed-
ing, and major extracranial bleeding. Intracranial and spinal bleed-
ing were defined as a neurologic deficit of sudden or subacute
onset confirmed by means of computed tomographic scanning,
surgical investigation, or autopsy. Major extracranial bleeding was
defined as an acute bleeding event that led to death or hospital
admission or treatment of bleeding; bleeding that led to hospital
admission for diagnostic procedures only was not considered ma-
jor. Bleeding caused by trauma was also excluded. We also ex-
cluded all complications that occurred during hospitalization for a
different reason because other diseases, interventions, and diag-
nostic procedures might affect the risk of complications far more
than the intensity of the anticoagulant therapy.7,8
Patients
Demographic data and preoperative cardiac information are given
in Table 1. With respect to preoperative heart rhythm, 78% of
patients had chronic atrial fibrillation. In May 1992, the Cox maze
procedure was introduced. Between May 1992 and December
1994, the Cox maze III procedure was the procedure primarily
performed. A modified maze III procedure (Kosakai maze) was
performed until May 1998. The cryo-maze procedure was used
thereafter. Details of these procedures have been previously de-
scribed.6,9 Five hundred thirty-three (66%) patients had St Jude
Medical valves (St Jude Medical, Inc, St Paul, Minn). The remain-
ing patients had a variety of valves including CarboMedics (n 
125; Sulzer Carbomedics, Inc, Austin, Tex), Bjo¨rk-Shiley (n 70,
in our early experience; Shiley, Inc, Irvine, Calif), ATS (n  47;
ATS Medical, Inc, Minneapolis, Minn), Omniscience (n  29;
Medical Inc, Inver Grove Heights, Minn), and other valves (n 
8). All valves were placed in the antianatomic position.
Assessment of the Intensity of Anticoagulant Therapy
The incidence of adverse events for specific levels of intensity of
anticoagulation were calculated as the ratio of the number of
events that took place when the prothrombin time was in a partic-
ular international normalized ratio (INR) range to the number of
patient-years during which the INR was at this level in the patient
population. This method has been described in detail previously.10
Statistical Methods
Survival and freedom from mortality, atrial fibrillation, and stroke
were estimated by using the Kaplan-Meier method. Survivorship
curves were compared with a log-rank test. The risks for death,
recurrence of atrial fibrillation, and stroke were analyzed by using
both univariate analysis and multivariate analysis with a Cox
proportional hazards model.
Results
Pathophysiology of Mitral Valve Disease and
Operative Findings
The pathophysiology of the mitral valve disease and the
nature of concomitant procedures are depicted in Table 2.
All patients underwent surgical intervention with mild hy-
pothermia. Antegrade crystalloid cardioplegia was primar-
ily used before 1987, and combined antegrade-retrograde
blood cardioplegia was extensively used thereafter. Fifty-
one percent (320/627) of the patients undergoing MVR
alone underwent concomitant ligation of the left atrial ap-
pendage, whereas 94% (173/185) of the patients who un-
derwent combined MVR and the maze procedure had the
left atrial appendage closed.
Postoperative Morbidity and Mortality
Hospital death occurred in 33 (4.1%) patients, and causes of
deaths are listed in Table 3. Postoperative complications
included bleeding (n  14), renal failure (n  6), intra-
aortic balloon pump insertion (n 4), mediastinitis (n 3),
left ventricular assist device insertion (n  3), left ventric-
ular rupture (n  3), and pneumothorax (n2).
TABLE 1. Preoperative clinical characteristics
Variable MVR (n  812)
Sex (M/F) 331/481
Age (range/median) 18-79 (58)
NYHA (class III/IV) No (%) 482 (60%)
History of stroke No (%) 138 (17%)
Left atrial thrombus No (%) 114 (14%)
Previous cardiac surgery No (%) 369 (45%)
Chronic AF No (%) 630 (78%)
NYHA, New York Heart Association; AF, atrial fibrillation.
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Survival and Late Mortality
All patients were observed for at least 6 months after their
operations. Actuarial 5-year, 10-year, and 15-year survivals
were 91.1%  1.8%, 88.4%  2.3%, and 85.4  3.2%,
respectively (Figure 1). There were 50 (6.2%) late deaths.
The causes of late deaths are listed in Table 3. Risk factors
for late mortality are depicted in Table 4.
Recurrence of Atrial Fibrillation
We chose to analyze recurrence of arrhythmia after the first
30 days because early postoperative atrial fibrillation might
be caused by different mechanisms than those of chronic
atrial fibrillation. Freedom from atrial fibrillation in the
group undergoing MVR alone at 8 years was 25.9% 3.2%
compared with 71.6%  6.3% in the combined MVR and
maze group (P  .0001, Figure 2). The incidence of stroke
was similar between the patients with sinus rhythm after a
maze procedure and those in native sinus rhythm (Appendix
1). Moreover, 46 patients with a combined MVR and maze
procedure had a recurrence of atrial fibrillation late after
surgical intervention.
Preoperative and Postoperative Medications
The spectrum and intensity of preoperative antiarrhythmic
drugs were similar in patients with and without a concom-
itant maze procedure. The number of antiarrhythmic agents
decreased over time in the combined maze-MVR group,
whereas the vast majority of patients undergoing MVR
alone continued to receive -blockers and digoxin for rate
control. All patients were taking warfarin, and the target
INR was 1.8 to 2.8.11,12 Only 27 patients took antiplatelet
agents; this did not affect the statistical results.
TABLE 2. Pathophisiology for mitral disease and concom-
itant procedure
Pathophisiology MVR (n  812)
MS No. (%) 237 (29%)
MR No. (%) 223 (27%)
MSR No. (%) 169 (21%)
PVF No. (%) 183 (23%)
Concomitant procedure
Maze procedure No (%) 185 (23%)
LAA closure No. (%) 493 (55%)
LAA plication No. (%) 148 (18%)
Tricuspid valve surgery No (%) 348 (43%)
TAP No. (%) 330 (41%)
TVR No. (%) 18 (2.2%)
CABG No. (%) 25 (3%)
Others No. (%) 126 (16%)
MS, Mitral stenosis; MR, mitral regurgitation; MSR, mitral stenosis/regur-
gitation; PVF, prosthetic valve failure; LAA, left atrial appendage; TAP,
tricuspid annuloplasty; TVR, tricuspid valve replacement; CABG, coronary
artery bypass grafting.
TABLE 3. Cause of early and late mortality
Early 33 (4.1%) LOS 18
MOF 7
Cerebral infarction 3
Cerebral bleeding 1
Others 4
Late 50 (6.2%) LOS 10
MOF 7
Cerebral infarction 8
Cerebral bleeding 7
Others 18
LOS, Low-output syndrome; MOF, multisystem organ failure.
Figure 1. Actuarial survival curve. Bar indicates 95% confidence
interval.
TABLE 4. Results of univariate and multivariate analysis
for late mortality
Variable
Univariate Multivariate
P value P value Hazard ratio 95% CI
Preoperative
NYHA class IV
.0090 .0032 3.39 1.50-7.65
Age 65 y .0059 .0001 2.71 1.50-4.92
CI, Confidence interval; NYHA, New York Heart Association.
Figure 2. Freedom from recurrence of atrial fibrillation (AF). Bar
indicates 95% confidence interval. MVR, Mitral valve replace-
ment.
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Incidence of Stroke After Surgical Intervention
Seventy-two patients had a late stroke; 65 (90%) patients
were in atrial fibrillation, and 47 (65%) patients had the left
atrial appendage closed. Irrespective of preoperative rhythm
(either in sinus rhythm or atrial fibrillation), closure of the
left atrial appendage did not have a significant effect on the
incidence of stroke, even in patients undergoing MVR
alone. At the time of their stroke, 63 (86%) patients had an
INR of greater than 1.8. Nine patients had stopped warfarin
for minor operations or dental care; their INR was less than
1.5.
Freedom from stroke 15 years after surgical intervention
was 90.7%  6.5% in patients with regular rhythm com-
pared with 73.8%  6.9% in patients with chronic atrial
fibrillation (P  .0001, Figure 3). Freedom from stroke 8
years after surgical intervention was 98.7%  2.3% in
patients who underwent a concomitant maze procedure
compared with 88.7%  2.6% in patients who underwent
MVR alone (P  .033, Figure 4). Three (6.5%) of the 46
patients with an unsuccessful maze procedure had a stroke
late after surgical intervention.
Incidence of Bleeding After Surgical Intervention
Seventy-six patients had major bleeding episodes after me-
chanical MVR. Twenty-three of those patients had intracra-
nial bleeding, and the remaining 53 patients had extracranial
bleeding. The INR at the time of either stroke or major
bleeding is shown in Figure 5.
Risk Factor for Late Stroke
By means of univariate analysis, chronic postoperative
atrial fibrillation (at 1 month after surgical intervention),
omission of a maze procedure, early year of surgical inter-
vention, and history of stroke were risk factors for late
stroke (Table 5). Closure of the left atrial appendage was not
a significant risk factor (P  .69). By means of multivariate
analysis, chronic atrial fibrillation and omission of the maze
procedure were the 2 most significant predictors of late
stroke (hazard ratio of 3.39 and 3.40, respectively), as
determined by using multivariate analysis. Neither closure
of the left atrial appendage nor left atrial plication had
prevented late stroke.
Discussion
Although MVR with mechanical prostheses is a safe and
commonly performed procedure, thromboembolic compli-
cations and bleeding related to the anticoagulant therapy
remain significant causes of late morbidity and mortality.13
Recently, we and others reported the effect of the maze
procedure on reducing the incidence of late stroke by re-
storing sinus rhythm. However, the risks for these compli-
cations and mortality after mechanical MVR were not fully
described.
The current retrospective study confirms that mechanical
MVR resulted in excellent 15-year survival (85%, Figure 1).
Furthermore, the only risk factors for late mortality were
preoperative New York Heart Association class IV and
older age (65 years, Table 4).
Figure 3. Freedom from stroke stratified by rhythm at 1 month
after surgical intervention. Bar indicates 95% confidence interval.
AF, Atrial fibrillation.
Figure 4. Freedom from stroke: effect of concomitant maze pro-
cedure. Bar indicates 95% confidence interval.
Figure 5. Effect of anticoagulation on stroke and major bleeding
after mechanical MVR.
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This study also confirms that greater than 25% of pa-
tients with chronic atrial fibrillation had a stroke during the
same 15-year period (Figure 3). Because 78% of the patients
who underwent MVR were in atrial fibrillation preopera-
tively (Table 1), restoration of sinus rhythm after surgical
intervention was a critical factor in preventing strokes after
mechanical MVR (Figure 3). The use of the maze procedure
is a logical strategy to prevent late strokes after MVR with
mechanical prostheses.
In the present study a maze procedure combined with
MVR resulted in 98.7% freedom from stroke, whereas only
89% of the patients undergoing MVR alone were free from
stroke 8 years after surgical intervention.
Moreover, chronic atrial fibrillation and the omission of
a maze procedure were the 2 major predictors of late stroke
after mechanical MVR. These results indicate that an ad-
junct maze procedure nearly eliminated the risk of late
stroke after MVR with mechanical prostheses.
Among 185 patients who underwent a concomitant maze
procedure, 3 patients had a stroke, but all of these patients
were in atrial fibrillation at the time of their strokes. More-
over, none had left atrial contraction, which was confirmed
by the absence of the a-wave on echocardiography. Patients
with a failed maze procedure might have a risk for late
stroke similar to that of patients with atrial fibrillation. The
radial approach or new radiofrequency techniques preserve
a more physiologic atrial transport function.14,15 Further
study is necessary to elucidate the role of left atrial contrac-
tion in eliminating left atrial thrombus.16
In addition to maintaining sinus rhythm by using a maze
procedure, closure of the left atrial appendage or reducing
the size of an enlarged left atrium might also be expected to
reduce the incidence of late stroke. In this study neither
closure of the left atrial appendage nor plication of the left
atrium prevented late stroke. However, more than 90% of
patients with a combined maze procedure had the left atrial
appendage closed, and the cutting and sewing in the original
maze procedure could certainly have reduced the size of the
left atrium. Differentiation of these factors might be diffi-
cult.
This study was also designed to examine the effect of
anticoagulation on the incidence of late stroke. Among 72
patients who had a late stroke, 63 had an INR considered
therapeutic (1.8-2.8) in the Japanese population (Figure
5).11,12 Thus therapeutic anticoagulation with warfarin
alone is insufficient to prevent late strokes after mechanical
MVR, especially in patients with chronic atrial fibrillation.
This was a significantly lower target level compared with
the American Heart Association/American College of Car-
diology guidelines,7 the recommendations of the American
College of Chest Physicians,17 and several European stud-
ies.18 However, recent studies from Japan indicate that
maintaining an INR level between 1.8 and 2.8 results in
lower bleeding and stroke rates compared with studies in the
United States or Europe.11,12 Accordingly, the guidelines of
the Japanese Circulation Society recommend a target INR
of 1.8 to 3.0 for patients after MVR with bileaflet mechan-
ical valves.19 The overall linearized risk of stroke in this
study was only 0.02 per year in patients with atrial fibrilla-
tion and 0.004 per year in patients with regular rhythm.
Moreover, the majority of patients who had major bleeding
had INRs between 2.0 and 3.3 at the time of their events.
Thus setting a higher INR might increase bleeding in our
population. A prospective randomized study to determine
the optimal anticoagulation regimen (eg, warfarin alone vs
warfarin plus antiplatelet agents) is necessary.3,8,18,20
The major limitation of our study is that it was not
randomized. The maze procedure was performed only after
1992, and therefore the follow-up period in the group un-
dergoing MVR alone versus those undergoing MVR plus
the maze procedure was different. The follow-up period for
the group undergoing MVR plus the maze procedure (mean,
4.45 patient-years; range, 0.5-12.4 patient-years; total, 828
patient years) was significantly shorter compared with that
of the group undergoing MVR alone (range, 0.5-22.9 pa-
tient-years; total, 5035 patient-years; P  .0001). Thus the
significantly higher freedom from stroke in the maze pro-
cedure group might be related to a shorter observation
period. However, our recent study regarding the impact of a
maze procedure with mitral valve repair and replacement
since 1992 indicated that the addition of a maze procedure
significantly reduced the incidence of stroke between the
groups during a comparable follow-up period.6 In addition
to this, the decision for or against an adjunctive maze
procedure reflected each surgeon’s experience. Regarding
anticoagulant therapy, the INR was known at the time of a
stroke or major bleeding event, but baseline INR was only
partly taken into account in this study. Thus the role of
compliance as a cause of instability in oral anticoagulant
therapy was not fully investigated.20
In conclusion, persistent atrial fibrillation was the most
significant risk factor for early and late stroke after mechan-
ical MVR. Restoration of sinus rhythm with the maze pro-
cedure nearly eliminated the risk of late stroke, whereas
neither closure of the left atrial appendage nor therapeutic
TABLE 5. Results of univariate and multivariate analysis
for late stroke
Variable
Univariate Multivariate
P value P value Hazard ratio 95% CI
Chronic AF .0001 .0004 3.39 1.72-6.67
No Maze procedure .003 .0279 3.40 1.14-10.14
Year of operation .013 .0524 1.61 0.99-2.61
History of Stroke .01 .0003 2.57 1.53-4.32
CI, Confidence interval; AF, atrial fibrillation.
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anticoagulation prevented this complication. Continuing ef-
forts to define the optimal oral anticoagulant therapy to
minimize the chances of stroke and bleeding are still nec-
essary.
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Discussion
Dr Cary Akins (Boston, Mass). I congratulate Dr Bando on
this nice presentation of his continuing evaluation of the effect of
concomitant maze procedures on the results of mitral valve sur-
gery, which was similar to his presentation at this meeting a year
ago. This year’s presentation enlarges last year’s study with the
inclusion of about 40 patients undergoing the combination of the
maze procedure and valve replacement and adds about 600 pa-
tients who had mechanical MVR from 1977 to 1992, none of
whom had a maze procedure. This study concludes, as last year’s
study did, that sinus rhythm is associated with better long-term
neurologic results but that sinus rhythm apparently has no demon-
strable effect on long-term survival.
I have several questions about the study design, the first con-
cerning the mechanical prostheses implanted because we know
that different prostheses have different thrombogenic potentials.
Did all of the patients in this study going back to 1977 receive the
same mechanical prosthesis? If different prostheses were used, was
prosthesis type inserted as a variable in the Cox analysis?
Dr Bando. Thank you very much, Dr Akins, for your excellent
questions. Regarding the type of valves, among these 812 patients,
533 patients had a St Jude mechanical valve, and the remaining
valves include the CarboMedics valve in 125 patients and, re-
cently, the ATS valve in 47 patients. Earlier in our experience, the
Bjo¨rk-Shiley valve was used in 70 patients, and the Omniscience
valve was used in 23 patients. We did analyze the type of valves
as potential predictors in univariate and multivariate analyses, and
these were entered into a Cox proportional hazards model, but
none of the valve types came out as a risk factor for either late
mortality or late stroke.
Dr Akins. My second question focuses on the effect of oblit-
eration of the left atrial appendage on late stroke. The authors
include in their statistical analysis of this part of the study patients
who had a concomitant maze procedure. Wouldn’t it be better to
eliminate the maze patients and analyze only patients who had a
MVR with or without obliteration of the left atrial appendage?
Dr Bando. That is a very excellent point, Dr Akins. Removing
185 patients, we have 627 patients undergoing MVR alone, and if
Appendix Figure 1. Freedom from stroke in patients with sinus
rhythm after the maze procedure versus freedom from stroke in
those in native sinus rhythm.
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